Researcher finds Baxdelta2 tumor suppressor can be generated in some colon cancer cells

(Medical Xpress)—Illinois Institute of Technology researcher Jialing Xiang, who recently discovered Baxdelta2, the powerful tumor suppressor found only in mutated cells, has learned more about its cell death-causing mechanism and therapeutic implications.

Certain colon tumors with genetic microsatellite instability often lose Bax due to microsatellite mutation. But a Bax alternative isoform, Baxdelta2, can be "salvaged" from the mutated gene. Xiang has found that Baxdelta2-positive cells are selectively sensitive to chemotherapeutics through an unconventional signaling pathway. This means that colorectal tumors thought to have been "Bax-negative" may instead be able to generate the Baxdelta2 that will be beneficial for chemotherapeutic treatment.

Xiang and her team reported their findings in the journal Molecular Cancer Research. Their work is supported by the National Cancer Institute (NCI) in the National Institutes of Health (NIH).

The pro-apoptotic (cell death-causing) protein Bax is one of the universal tumor suppressors in our body. Loss of Bax will have a negative effect on the cellular "suicide" program and promote development. The ability to generate Baxdelta2 means the cancer cell might be triggered to re-start the apoptotic (cell death-causing) process.

"Discovery of Baxdelta2 will lead us to a better understanding of the 'Bax-negative' colon cancer and potentially provide targeted chemotherapeutics for treatment," said Xiang.

One of the areas that Xiang's team is working on is to find out how the production of Baxdelta2 is controlled and to identify drugs that can enhance Baxdelta2 production in .

More information: "Baxdelta2 Promotes Apoptosis through Caspase-8 Activation in Microsatellite Unstable Colon Cancer." Honghong Zhang, Yuting Lin, Adriana Manas, Yu Zhao, Mitchell F. Denning, Li Ma, and Jialing Xiang. Mol Cancer Res molcanres.0162.2014; Published OnlineFirst May 19, 2014; DOI: 10.1158/1541-7786.MCR-14-0162

add to favorites email to friend print save as pdf

Related Stories

Key protein that may cause cancer cell death identified

Jan 16, 2009

Researchers at A*STAR's Institute of Molecular and Cell Biology (IMCB) have become the first to discover and characterize a human protein called Bax-beta (Baxβ), which can potentially cause the death of cancer cells ...

New strategy directly activates cellular 'death protein'

May 31, 2012

Researchers at Dana-Farber/Children's Hospital Cancer Center have devised a strategy to directly activate a natural "death" protein, triggering the self-destruction of cells. They say the development could represent a new ...

Immune cell death defects linked to autoimmune diseases

Jan 23, 2013

Melbourne researchers have discovered that the death of immune system cells is an important safeguard against the development of diseases such as type 1 diabetes, rheumatoid arthritis and lupus, which occur ...

Recommended for you

Scientists to use tiny particles to fight big diseases

1 hour ago

Physicians will tell you: They are not winning the war on ovarian cancer. But FIU researchers are crafting a new weapon for that battle. A group of scientists have combined medicine and advanced nanotechnological engineering ...

User comments